Compared with women with ASC-US, the results of women with ASC-H on routine Pap are much more likely to have moderate to severe CIN, with estimates ranging widely from 24% to 94%. As a result ...

The first author (A Kathrine Lie) is the project manager for a study evaluating different commercially available HPV tests in the Norwegian Coordinated Cervical Cancer Screening Program ...

Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

Global disparities exist in the burden of cervical cancer. Only 11 out of the 185 countries and regions reported an age-standardized incidence rates (ASIR) lower than the World Health Organization’s ...

Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

Millions of women who missed early HPV vaccination opportunities now face rising cervical cancer rates. New research shows screening rates dropping precisely when they're needed most.

Schistosoma haematobium can trigger cancer-related gene activity in the cervix, increasing the risk for cervical cancer, according to data presented at the ESCMID Global meeting.

Cervical cancer constitutes a formidable health challenge imperiling the well-being and lives of women globally, particularly in underdeveloped nations. The survival rates among patients diagnosed ...